Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs

Journal of Viral Hepatitis
Watcharasak ChotiyaputtaA S F Lok

Abstract

Medication adherence is important for the success of nucleos(t)ide analogue (NUC) treatment for chronic hepatitis B. The aims of this study were to determine adherence to NUCs and factors associated with NUC adherence and to correlate NUC adherence with the occurrence of virological breakthroughs in patients with chronic hepatitis B. Consecutive patients with chronic hepatitis B receiving NUC were asked to complete a survey every 3 months. Adherence was also assessed by healthcare providers in the clinic. Adherence rate was defined as the per cent of days the patients took their hepatitis B virus medications during the last 30 days. A total of 111 patients were studied. The mean age was 47.7 years, 73.9% were men, 57.7% were Asian, 42.3% had postgraduate education and 80% had private insurance. Sixty-nine (74.1%) patients reported 100% adherence in the survey, while 78 (83.9%) reported 100% adherence to their healthcare providers. Patients with 100% adherence based on the survey were older (P = 0.02), more likely to be men (P = 0.006), and had higher annual household income (P = 0.04) than those with <100% adherence. In the 80 patients who completed three surveys, viral breakthrough was observed in 1/46 (2.2%) with 100% adheren...Continue Reading

References

Jul 6, 2000·Annals of Internal Medicine·D L PatersonN Singh
May 16, 2001·Annals of Internal Medicine·H LiuN S Wenger
Nov 6, 2001·The American Journal of Gastroenterology·S V KaneS B Hanauer
Feb 28, 2003·The New England Journal of Medicine·Stephanos J HadziyannisUNKNOWN Adefovir Dipivoxil 438 Study Group
Feb 28, 2003·The New England Journal of Medicine·Patrick MarcellinUNKNOWN Adefovir Dipivoxil 437 Study Group
Jun 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christopher E WestlandUNKNOWN 437 and 438 Study Teams
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jean-Jacques ParientiRenaud Verdon
Aug 18, 2004·Heart·A K Mantel-TeeuwisseR M C Herings
Dec 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Franco MaggioloFredy Suter
Jan 6, 2005·The Journal of Infectious Diseases·P Richard HarriganJulio S G Montaner
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Nov 4, 2005·The New England Journal of Medicine·Ronald J Campbell
Mar 10, 2006·The New England Journal of Medicine·Ting-Tsung ChangUNKNOWN BEHoLD AI463022 Study Group
Mar 10, 2006·The New England Journal of Medicine·Ching-Lung LaiUNKNOWN BEHoLD AI463027 Study Group
Apr 21, 2006·Journal of Managed Care Pharmacy : JMCP·Thomas J BramleyFeride Frech-Tamas
Jan 12, 2007·British Journal of Clinical Pharmacology·Marie-Hélène BouchardSylvie Perreault
Apr 18, 2007·Annals of Internal Medicine·Jean B NachegaGary Maartens
Dec 21, 2007·The New England Journal of Medicine·Ching-Lung LaiUNKNOWN Globe Study Group
Jul 23, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·L A DonnellyP T Donnan
Dec 5, 2008·The New England Journal of Medicine·Patrick MarcellinFranck Rousseau
Oct 5, 2010·Journal of Hepatology·Watcharasak ChotiyaputtaAnna S F Lok

❮ Previous
Next ❯

Citations

Aug 1, 2013·The Journal of Infectious Diseases·Monique van VelzenGeorges M G M Verjans
Oct 31, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Young-Joo YangHan Chu Lee
Jan 14, 2016·Infectious Diseases and Therapy·Rodrigo Martins AbreuSuzane Kioko Ono
Sep 14, 2015·International Journal of Clinical Pharmacy·Jae Hee KimNeung Hwa Park
Apr 23, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anders BoydKarine Lacombe
May 6, 2015·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Lotte G van VlerkenKarel J van Erpecum
Aug 10, 2016·Journal of Viral Hepatitis·N AllardB Cowie
Feb 16, 2018·Global Health Action·Kerui XuJian-Jun Zhang
Apr 5, 2019·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Hirofumi GoMegumi Shimada
Nov 7, 2019·European Journal of Gastroenterology & Hepatology·Spilios ManolakopoulosGeorge Papatheodoridis
Jul 12, 2017·Virus Evolution·Kristen K IrwinJeffrey D Jensen
Sep 1, 2016·European Journal of Hospital Pharmacy. Science and Practice·Yolanda Borrego IzquierdoRamón Morillo Verdugo
Sep 4, 2015·World Journal of Gastroenterology : WJG·Qian QiuLi Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.